心血管康复医学杂志
心血管康複醫學雜誌
심혈관강복의학잡지
JOURNAL OF CARDIOVASCULAR REHABILITATION MEDICINE
2015年
2期
156-159
,共4页
潘永东%宋炳慧%王书清%姜波%谢广宇
潘永東%宋炳慧%王書清%薑波%謝廣宇
반영동%송병혜%왕서청%강파%사엄우
利钠肽,脑%半胱氨酸蛋白酶抑制物C%急性冠状动脉综合征
利鈉肽,腦%半胱氨痠蛋白酶抑製物C%急性冠狀動脈綜閤徵
리납태,뇌%반광안산단백매억제물C%급성관상동맥종합정
Natriuretic peptide,brain%Cysteine proteinase inhibitors%Acute coronary syndrome
目的:血浆N末端脑钠肽前体,胱抑素C检测结合急性冠状动脉事件注册评分评估ACS患者心功能,主要不良心血管事件( M ACE )的作用.方法:入选 ACS 患者136例,根据 GRACE评分分为低(29例)、中(39例)、高危组(68例),检测各组血清Cys C及血浆 NT‐proBNP水平,心功能,统计3、6个月内 MACE发生率。结果:在ACS患者中,与低危组比较,中危组和高危组NT‐proBNP [(165.80±51.62) ng/L比(193.13±74.64) ng/L比(985.45±152.69) ng/L]、Cys C [(0.83±0.38) mg/L比(0.9±0.25) mg/L比(1.23±0.23) mg/L]水平显著升高,左室舒张末期内径[6个月:(50±3) mm比(55±3) mm比(59±5) mm]明显增加,左室射血分数[LVEF ,6个月: (55±7)%比(49±5)%比(40±7)%]显著降低,不良心血管事件发生率(6个月:2.94%比9.55%比30.88%)明显升高,且高危组上述各项(除LVEF显著降低外)均显著高于中危组, P<0.05或<0.01;Pearson相关分析显示, NT‐proBNP、Cys C水平与 GRACE危险积分分别呈正相关(r=0.72, P<0.05;r=0.65, P<0.05)。结论:NT‐proBNP及Cys C水平检测结合GRACE评分,能准确反映心功能、评估预后。
目的:血漿N末耑腦鈉肽前體,胱抑素C檢測結閤急性冠狀動脈事件註冊評分評估ACS患者心功能,主要不良心血管事件( M ACE )的作用.方法:入選 ACS 患者136例,根據 GRACE評分分為低(29例)、中(39例)、高危組(68例),檢測各組血清Cys C及血漿 NT‐proBNP水平,心功能,統計3、6箇月內 MACE髮生率。結果:在ACS患者中,與低危組比較,中危組和高危組NT‐proBNP [(165.80±51.62) ng/L比(193.13±74.64) ng/L比(985.45±152.69) ng/L]、Cys C [(0.83±0.38) mg/L比(0.9±0.25) mg/L比(1.23±0.23) mg/L]水平顯著升高,左室舒張末期內徑[6箇月:(50±3) mm比(55±3) mm比(59±5) mm]明顯增加,左室射血分數[LVEF ,6箇月: (55±7)%比(49±5)%比(40±7)%]顯著降低,不良心血管事件髮生率(6箇月:2.94%比9.55%比30.88%)明顯升高,且高危組上述各項(除LVEF顯著降低外)均顯著高于中危組, P<0.05或<0.01;Pearson相關分析顯示, NT‐proBNP、Cys C水平與 GRACE危險積分分彆呈正相關(r=0.72, P<0.05;r=0.65, P<0.05)。結論:NT‐proBNP及Cys C水平檢測結閤GRACE評分,能準確反映心功能、評估預後。
목적:혈장N말단뇌납태전체,광억소C검측결합급성관상동맥사건주책평분평고ACS환자심공능,주요불양심혈관사건( M ACE )적작용.방법:입선 ACS 환자136례,근거 GRACE평분분위저(29례)、중(39례)、고위조(68례),검측각조혈청Cys C급혈장 NT‐proBNP수평,심공능,통계3、6개월내 MACE발생솔。결과:재ACS환자중,여저위조비교,중위조화고위조NT‐proBNP [(165.80±51.62) ng/L비(193.13±74.64) ng/L비(985.45±152.69) ng/L]、Cys C [(0.83±0.38) mg/L비(0.9±0.25) mg/L비(1.23±0.23) mg/L]수평현저승고,좌실서장말기내경[6개월:(50±3) mm비(55±3) mm비(59±5) mm]명현증가,좌실사혈분수[LVEF ,6개월: (55±7)%비(49±5)%비(40±7)%]현저강저,불양심혈관사건발생솔(6개월:2.94%비9.55%비30.88%)명현승고,차고위조상술각항(제LVEF현저강저외)균현저고우중위조, P<0.05혹<0.01;Pearson상관분석현시, NT‐proBNP、Cys C수평여 GRACE위험적분분별정정상관(r=0.72, P<0.05;r=0.65, P<0.05)。결론:NT‐proBNP급Cys C수평검측결합GRACE평분,능준학반영심공능、평고예후。
Objective:To assess effect of detection of plasma N terminal pro brain natriuretic peptide (NT‐proBNP) and serum cystatin C (Cys C) combined Global Registry of Acute Coronary Events (GRACE) score on heart func‐tion and prognosis in patients with acute coronary syndrome (ACS) .Methods :According to GRACE score ,a total of 136 ACS patients were divided into low risk group (n=29) ,intermediate risk group (n=39) and high risk group (n=68) .Serum Cys C level and plasma NT‐proBNP level were measured in all groups .Incidence rate of major ad‐verse cardiovascular events (MACE) within three and six months was counted .Results:Among ACS patients ,com‐pared with low risk group ,there were significant rise in levels of NT‐proBNP [ (165.80 ± 51.62) ng/L vs .(193.13 ± 74.64) ng/L vs .(985.45 ± 152.69) ng/L] and Cys C [ (0.83 ± 0.38) mg/L vs .(0.9 ± 0.25) mg/L vs .(1.23 ± 0.23) mg/L] ,left ventricular end‐diastolic diameter [six months: (50 ± 3) mm vs .(55 ± 3) mm vs .(59 ± 5) mm] ,significant reduction in left ventricular ejection fraction [LVEF ,six months: (55 ± 7)% vs .(49 ± 5)% vs . (40 ± 7)% ] ,and significant rise in incidence rate of MACE (six months:2.94% vs .9.55% vs .30.88% ) ,and a‐bove indexes in high risk group were significantly higher than those of intermediate risk group except LVEF signifi‐cantly reduced , P<0.05 or <0.01 ;Pearson correlation analysis indicated that NT‐proBNP and Cys C levels were positively correlated with GRACE score (r=0.72 , P<0.05 ; r=0.65 , P<0.05) respectively .Conclusion:NT‐proBNP and Cys C level detection combined GRACE score could exactly response heart function and prognosis .